(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide

C81H143NO18 — CID 165213217

IUPAC(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCC
InChIInChI=1S/C81H143NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-29-30-31-32-33-34-35-36-37-39-41-43-45-47-49-51-53-55-57-59-69(87)82-64(65(86)58-56-54-52-50-48-46-44-42-40-38-26-24-22-20-18-16-14-12-10-8-6-4-2)63-95-79-75(93)72(90)77(67(61-84)97-79)100-81-76(94)73(91)78(68(62-85)98-81)99-80-74(92)71(89)70(88)66(60-83)96-80/h5,7,11,13,17,19,23,25,40,42,48,50,56,58,64-68,70-81,83-86,88-94H,3-4,6,8-10,12,14-16,18,20-22,24,26-39,41,43-47,49,51-55,57,59-63H2,1-2H3,(H,82,87)/b7-5-,13-11-,19-17-,25-23-,42-40+,50-48+,58-56+
InChIKeyFZMLZIDFMYYPKK-SFSFJQFRSA-N
MW1419.02 g/mol
LogP13.00
Rot. Bonds62

About (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide

(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide (PubChem CID 165213217) has the molecular formula C81H143NO18 and a molecular weight of 1419.02 g/mol. Its IUPAC name is (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide.

Molecular Properties

Compound Name(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide
PubChem CID165213217
Molecular FormulaC81H143NO18
Molecular Weight1419.02 g/mol
Exact Mass1418.03
IUPAC Name(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCC
InChIInChI=1S/C81H143NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-29-30-31-32-33-34-35-36-37-39-41-43-45-47-49-51-53-55-57-59-69(87)82-64(65(86)58-56-54-52-50-48-46-44-42-40-38-26-24-22-20-18-16-14-12-10-8-6-4-2)63-95-79-75(93)72(90)77(67(61-84)97-79)100-81-76(94)73(91)78(68(62-85)98-81)99-80-74(92)71(89)70(88)66(60-83)96-80/h5,7,11,13,17,19,23,25,40,42,48,50,56,58,64-68,70-81,83-86,88-94H,3-4,6,8-10,12,14-16,18,20-22,24,26-39,41,43-47,49,51-55,57,59-63H2,1-2H3,(H,82,87)/b7-5-,13-11-,19-17-,25-23-,42-40+,50-48+,58-56+
InChIKeyFZMLZIDFMYYPKK-SFSFJQFRSA-N
XLogP13.00
TPSA307.01 Ų
H-Bond Donors12
H-Bond Acceptors18
Rotatable Bonds62
Heavy Atoms100
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001419.02
LogP ≤ 513.00
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide?
The IUPAC name of (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide (CID 165213217) is (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide.
What is the SMILES notation for (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide?
The canonical SMILES for (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide is CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCC.
What is the InChIKey of (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide?
The InChIKey is FZMLZIDFMYYPKK-SFSFJQFRSA-N. The full InChI is InChI=1S/C81H143NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-29-30-31-32-33-34-35-36-37-39-41-43-45-47-49-51-53-55-57-59-69(87)82-64(65(86)58-56-54-52-50-48-46-44-42-40-38-26-24-22-20-18-16-14-12-10-8-6-4-2)63-95-79-75(93)72(90)77(67(61-84)97-79)100-81-76(94)73(91)78(68(62-85)98-81)99-80-74(92)71(89)70(88)66(60-83)96-80/h5,7,11,13,17,19,23,25,40,42,48,50,56,58,64-68,70-81,83-86,88-94H,3-4,6,8-10,12,14-16,18,20-22,24,26-39,41,43-47,49,51-55,57,59-63H2,1-2H3,(H,82,87)/b7-5-,13-11-,19-17-,25-23-,42-40+,50-48+,58-56+.
What are the key properties of (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide?
(24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide has a molecular weight of 1419.02 g/mol, XLogP of 13.00, 62 rotatable bonds, 12 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptacosa-4,8,12-trien-2-yl]hexatriaconta-24,27,30,33-tetraenamide is sourced from PubChem (CID 165213217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).